Literature DB >> 28433377

Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?

Matthew D Galsky1, John P Sfakianos2, Bart S Ferket3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28433377     DOI： 10.1016/j.eururo.2017.04.012

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   24.267


× No keyword cloud information.
  2 in total

1.  Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Authors:  Fern Anari; John O'Neill; Woonyoung Choi; David Y T Chen; Mohammed Haseebuddin; Alexander Kutikov; Essel Dulaimi; R Katherine Alpaugh; Karthik Devarajan; Richard E Greenberg; Marijo Bilusic; Yu-Ning Wong; Rosalia Viterbo; Jean H Hoffman-Censits; Costas D Lallas; Edouard J Trabulsi; Marc Smaldone; Daniel M Geynisman; Matthew Zibelman; Jianqing Lin; W Kevin Kelly; Robert Uzzo; David McConkey; Elizabeth R Plimack
Journal:  Eur Urol Oncol       Date:  2018-06-06

Review 2.  The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.

Authors:  Ho Won Kang; Wun-Jae Kim; Seok Joong Yun
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.